Literature Collection

Magnifying Glass
Collection Insights

12K+

References

11K+

Articles

1600+

Grey Literature

4800+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
12780 Results
8781
Predictors of acceptance of offered care management intervention services in a quality improvement trial for dementia
Type: Journal Article
Authors: Marwa Kaisey, Brian Mittman, Marjorie Pearson, Karen I. Connor, Joshua Chodosh, Stefanie D. Vassar, France T. Nguyen, Barbara G. Vickrey
Year: 2011
Topic(s):
General Literature See topic collection
8783
Predictors of buprenorphine initial outpatient maintenance and dose taper response among non-treatment-seeking heroin dependent volunteers.
Type: Journal Article
Authors: Eric A. Woodcock, Leslie H. Lundahl, Mark K. Greenwald
Year: 2015
Topic(s):
Opioids & Substance Use See topic collection
8786
Predictors of depression screening rates of nurses receiving a personal digital assistant-based reminder to screen
Type: Journal Article
Authors: R. Schnall, L. M. Currie, H. Jia, R. M. John, N. J. Lee, O. Velez, S. Bakken
Year: 2010
Publication Place: United States
Abstract: The purpose of this study was to determine if race/ethnicity, payer type, or nursing specialty affected depression screening rates in primary care settings in which nurses received a reminder to screen. The sample comprised 4,160 encounters in which nurses enrolled in advanced practice training were prompted to screen for depression using the Patient Health Questionnaire (PHQ)-2/PHQ-9 integrated into a personal digital assistant-based clinical decision support system for depression screening and management. Nurses chose to screen in response to 52.5% of reminders. Adjusted odds ratios showed that payer type and nurse specialty, but not race/ethnicity, significantly predicted proportion of patients screened.
Topic(s):
Financing & Sustainability See topic collection
,
HIT & Telehealth See topic collection
8787
Predictors of dropout from inpatient opioid detoxification with buprenorphine: a chart review
Type: Journal Article
Authors: A. Hakansson, E. Hallen
Year: 2014
Publication Place: Egypt
Abstract: Inpatient withdrawal treatment (detoxification) is common in opioid dependence, although dropout against medical advice often limits its outcome. This study aimed to assess baseline predictors of dropout from inpatient opioid detoxification with buprenorphine, including age, gender, current substance use, and type of postdetoxification planning. A retrospective hospital chart review was carried out for inpatient standard opioid detoxifications using buprenorphine taper, in a detoxification ward in Malmo, Sweden (N = 122). Thirty-four percent of patients (n = 42) dropped out against medical advice. In multivariate logistic regression, dropout was significantly associated with younger age (OR 0.93 [0.89-0.97]) and negatively predicted by inpatient postdetoxification plan (OR 0.41 [0.18-0.94]), thus favouring an inpatient plan as opposed to outpatient treatment while residing at home. Dropout was unrelated to baseline urine toxicology. In opioid detoxification, patients may benefit from a higher degree of postdetoxification planning, including transition to residential treatment, in order to increase the likelihood of a successful detoxification and treatment entry. Young opioid-dependent patients may need particular attention in the planning of detoxification.
Topic(s):
Opioids & Substance Use See topic collection
8788
Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study
Type: Journal Article
Authors: Alexandria Macmadu, Kimberly Paull, Rouba Youssef, Sivakumar Batthala, Kevin H. Wilson, Elizabeth A. Samuels, Jesse L. Yedinak, Brandon D. L. Marshall
Year: 2021
Topic(s):
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
8789
Predictors of Family Medicine Patient Retention in Opioid Medication-Assisted Treatment
Type: Journal Article
Authors: K. Justesen, S. A Hooker, M. D. Sherman, M. Lonergan-Cullum, T. Nissly, R. Levy
Year: 2020
Publication Place: United States
Topic(s):
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
8791
Predictors of Health Behavior Change After an Integrative Medicine Inpatient Program
Type: Journal Article
Authors: Holger Cramer, Romy Lauche, Susanne Moebus, Andreas Michalsen, Jost Langhorst, Gustav Dobos, Anna Paul
Year: 2014
Topic(s):
General Literature See topic collection
8794
Predictors of linkage to an opioid treatment program and methadone treatment retention following hospital discharge in a safety-net setting
Type: Journal Article
Authors: Hannah R. Tierney, Sarah W. Takimoto, Soraya Azari, Scott Steiger, Marlene Martin
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
8796
Predictors of mental health and substance use disorder treatment use over 3 years among rural adults using stimulants
Type: Journal Article
Authors: Michael A. Cucciare, Songthip T. Ounpraseuth, Geoffrey M. Curran, Brenda M. Booth
Year: 2019
Topic(s):
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
8797
Predictors of Metabolic Syndrome (MetS) and the benefits of using the MetS diagnosis for people with serious and persistent mental illness
Type: Journal Article
Authors: K. Noam, C. Bory, E. Flanagan, J. Wigglesworth, R. Plant
Year: 2025
Topic(s):
Healthcare Disparities See topic collection
8798
Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?
Type: Journal Article
Authors: D. Shah, S. Brown, N. Hagemeier, S. Zheng, A. Kyle, J. Pryor, N. Dankhara, P. Singh
Year: 2016
Publication Place: Switzerland
Abstract: BACKGROUND: Buprenorphine is a semi-synthetic opioid used for the treatment of opioid dependence. Opioid use, including buprenorphine, has been increasing in recent years, in the general population and in pregnant women. Consequently, there has been a rise in frequency of neonatal abstinence syndrome (NAS), associated with buprenorphine use during pregnancy. The purpose of this study was to investigate correlations between buprenorphine and buprenorphine-metabolite concentrations in cord blood and onset of NAS in buprenorphine exposed newborns. METHODS: Nineteen (19) newborns who met inclusion criteria were followed after birth until discharge in a double-blind non-intervention study, after maternal consent. Cord blood and tissue samples were collected and analyzed by liquid chromatography-mass spectrometry (LC-MS) for buprenorphine and metabolites. Simple and multiple logistic regressions were used to examine relationships between buprenorphine and buprenorphine metabolite concentrations in cord blood and onset of NAS, need for morphine therapy, and length of stay. RESULTS: Each increase in 5 ng/ml level of norbuprenorphine in cord blood increases odds of requiring treatment by morphine 2.5 times. Each increase in 5 ng/ml of buprenorphine-glucuronide decreases odds of receiving morphine by 57.7 %. Along with concentration of buprenorphine metabolites, birth weight and gestational age also play important roles, but not maternal buprenorphine dose. CONCLUSIONS: LC-MS analysis of cord blood concentrations of buprenorphine and metabolites is an effective way to examine drug and metabolite levels in the infant at birth. Cord blood concentrations of the active norbuprenorphine metabolite and the inactive buprenorphine-glucuronide metabolite show promise in predicting necessity of treatment of NAS. These finding have implications in improving patient care and reducing healthcare costs if confirmed in a larger sample.
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
8799
Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone
Type: Journal Article
Authors: A. Kline, J. M. Williams, M. L. Steinberg, D. Mattern, M. Chesin, S. Borys, V. Chaguturu
Year: 2023
8800
Predictors of outcome after short-term stabilization with buprenorphine.
Type: Journal Article
Authors: Maureen Hillhouse, Catherine P. Canamar, Walter Ling
Year: 2013
Topic(s):
Opioids & Substance Use See topic collection